Indeed, NEDD4L is significantly downregulated at the gene and protein level in colorectal cancer (Eide et al., 2013; Tanksley et al., 2013), non-small cell lung cancer and breast cancer (Guarnieri et al., 2018) amongst others, and is associated with a poor prognosis. Here, NEDD4L is linked to breast carcinoma.